I. Crozier

B. Merkely, I. Crozier, L. Molnár, 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Therapy From a Novel Substernal Lead The

P. Neužil, B. Knight, B. Merkely, 2019 .

Comparison of high sensitivity and contemporary troponin assays for the early detection of acute myocardial infarction in the emergency department

I. Crozier, C. Florkowski, M. Than, 2011, Annals of clinical biochemistry.

Longevity of the Subcutaneous Implantable Defibrillator: Long-Term Follow-Up of the European Regulatory Trial Cohort

L. Jordaens, R. Cappato, D. Theuns, 2015, Circulation. Arrhythmia and electrophysiology.

A Novel Visually Guided Radiofrequency Balloon Ablation Catheter for Pulmonary Vein Isolation

P. Neužil, D. Hooks, A. Aidietis, 2021, Circulation. Arrhythmia and electrophysiology.

Cardiac involvement in systemic lupus erythematosus detected by echocardiography.

M. Nicholls, I. Crozier, M. Milne, 1990, The American journal of cardiology.

CARDIAC HYPERTROPHY IN OLD AGE

J. Woo, I. Crozier, M. Milne, 1989, The Lancet.

Studies on the secretion, metabolism and action of atrial natriuretic peptide in man.

R. Cuneo, E. Espiner, M. Nicholls, 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

High sensitivity troponin outperforms contemporary assays in predicting major adverse cardiac events up to two years in patients with chest pain

I. Crozier, C. Florkowski, M. Than, 2011, Annals of clinical biochemistry.

Coronary artery spasm due to thyrotoxicosis.

I. Crozier, Krystina Common, K. Milburn, 2012, The New Zealand medical journal.

THE NEW ZEALAND MEDICAL JOURNAL

I. Crozier, Krystina Common, K. Milburn, 2011 .

Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease.

A. Richards, E. Espiner, M. Nicholls, 1993, British heart journal.

Sympathetic nervous system during converting enzyme inhibition.

R. Kay, M. Nicholls, I. Crozier, 1989, The American journal of medicine.

Thecourseofidiopathic dilated cardiomyopathy in NewZealand

H. Ikram, I. Crozier, E. Wells, 1987 .

Electrophysiology assessment and radiofrequency ablation of arrhythmias in adult patients with congenital heart defects: the Christchurch experience.

D. Hooks, M. Daly, I. Crozier, 2014, The New Zealand medical journal.

Direct Left Atrial Pressure Monitoring in Ambulatory Heart Failure Patients: Initial Experience With a New Permanent Implantable Device

William T. Abraham, Saibal Kar, Robert N. Doughty, 2007, Circulation.

The subcutaneous defibrillator will replace the transvenous defibrillator

I. Crozier, 2011, Journal of Interventional Cardiac Electrophysiology.

Antianginal, hemodynamic and coronary vascular effects of captopril in stable angina pectoris.

A. Richards, H. Ikram, C. Webb, 1990, The American journal of cardiology.

Atrial Natriuretic Peptide in Humans: Production and Clearance by Various Tissues

E. Espiner, M. Nicholls, H. Ikram, 1986, Hypertension.

Endopeptidase 24.11 inhibition by SCH 42495 in essential hypertension.

C. Frampton, A. Richards, E. Espiner, 1993, Hypertension.

The performance of high sensitivity troponin for the diagnosis of acute myocardial infarction is underestimated

I. Crozier, C. Florkowski, M. Than, 2012, Clinical chemistry and laboratory medicine.

Brain natriuretic peptide: natriuretic and endocrine effects in essential hypertension

C. Frampton, A. Richards, E. Espiner, 1993, Journal of hypertension.

CARDIAC SECRETION OF ATRIAL NATRIURETIC PEPTIDE

R. Cuneo, E. Espiner, M. Nicholls, 1985, The Lancet.

B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction

C. Frampton, A. Richards, E. Espiner, 2003, Circulation.

Cardiac natriuretic peptides in heart failure.

A. Richards, E. Espiner, M. Nicholls, 1993, Annals of medicine.

Neurohormonal changes after acute myocardial infarction. Relationships with haemodynamic indices and effects of ACE inhibition.

C. Frampton, A. Richards, M. Nicholls, 1995, European heart journal.

Safety and Efficacy of a Subcutaneous Implantable-Defibrillator

M. Gold, B. Knight, R. Weiss, 2012 .

Comparative Pathology of an Implantable Left Atrial Pressure Sensor

D. Gutfinger, F. Clubb, W. Abraham, 2013, ASAIO journal.

Relation between left atrial diameter and plasma atrial natriuretic peptide, renin and vasopressin.

E. Espiner, M. Nicholls, H. Ikram, 1986, The American journal of cardiology.

Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II

G. Wittert, C. Frampton, E. Espiner, 1993, Journal of hypertension.

CHRISTCHURCH CARDIOENDO-CRINE RESEARCH GROUP; AUSTRALIA-NEW ZEALAND HEART FAILURE GROUP. COMPARISON OF BT-YPE NATRIURETIC PEPTIDES FOR ASSESSMENT OF CARDIAC FUNCTION AND PROGNOSIS IN STABLE ISCHEMIC HEART DISEASE

R. Doughty, S. MacMahon, N. Sharpe, 2006 .

Acute Inhibition of Endopeptidase 24.11 in Essential Hypertension: SCH 34826 Enhances Atrial Natriuretic Peptide and Natriuresis Without Lowering Blood Pressure

C. Frampton, A. Richards, E. Espiner, 1992, Journal of cardiovascular pharmacology.

The extravascular implantable cardioverter‐defibrillator: The pivotal study plan

C. Leclercq, B. Knight, Sarah Willey, 2021, Journal of cardiovascular electrophysiology.

plasma catecholamines . relation to systemic arterial pressure , and primary pulmonary hypertension : variability , Ambulatory pulmonary arterial pressure in

A. Richards, M. Nicholls, H. Ikram, 2004 .

Plasma brain natriuretic peptide and endopeptidase 24.11 inhibition in hypertension.

A. Richards, E. Espiner, M. Nicholls, 1993, Hypertension.

Twenty-four hour profile of the hypotensive action of felodipine in essential hypertension

M. Nicholls, H. Ikram, C. J. Low, 1990, Cardiovascular Drugs and Therapy.

Twenty-four hour profile of the anti-hypertensive action of isradipine in essential hypertension.

H. Ikram, C. J. Low, S. Foy, 1993, Blood pressure.

ATRIAL NATRIURETIC FACTOR IN HUMAN PATHOPHYSIOLOGY

A. Richards, E. Espiner, M. Nicholls, 1988, Clinical and experimental pharmacology & physiology.

THE PATTERN OF ATRIAL NATRIURETIC PEPTIDE RELEASE DURING VENTRICULAR TACHYCARDIA IN MAN

M. Nicholls, H. Ikram, I. Crozier, 1987, Clinical and experimental pharmacology & physiology.

Acute Myocardial Infarction and Stress Cardiomyopathy following the Christchurch Earthquakes

I. Crozier, R. Troughton, P. Bridgman, 2013, PloS one.

Two major earthquakes in Christchurch were not associated with increased ventricular arrhythmias: Analysis of implanted defibrillator diagnostics

M. Daly, I. Crozier, I. Melton, 2019, PloS one.

Decreases in cardiac catheter laboratory workload during the COVID‐19 level 4 lockdown in New Zealand

I. Crozier, J. Elliott, 2020, Internal medicine journal.

Patients with congenital heart disease: how to determine the eligibility for implantation of a subcutaneous implantable defibrillator?

D. Theuns, I. Crozier, 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Pulmonary hypertension as a consequence of alveolar capillary plugging by malignant megakaryocytes in essential thrombocythaemia.

D. Mcclean, I. Crozier, R. Fraser, 1996, Australian and New Zealand journal of medicine.

Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator.

C. Leclercq, L. Epstein, B. Knight, 2022, The New England journal of medicine.

Electrophysiological Effects of atrial Natriuretic Peptide on the Cardiac Conduction System in Man

H. Ikram, I. Crozier, A. Richards, 1993, Pacing and clinical electrophysiology : PACE.

Amino acid sequence of atrial natriuretic peptides in human coronary sinus plasma.

E. Espiner, I. Crozier, G. Nicholls, 1987, Biochemical and biophysical research communications.

ATRIAL NATRIURETIC PEPTIDE LEVELS IN CONGESTIVE HEART FAILURE IN MAN BEFORE AND DURING CONVERTING ENZYME INHIBITION

E. Espiner, M. Nicholls, H. Ikram, 1989, Clinical and experimental pharmacology & physiology.

Design and Preliminary Results of Sensing and Detection for an Extravascular Implantable Cardioverter-Defibrillator.

I. Crozier, C. Swerdlow, H. Haqqani, 2021, JACC. Clinical electrophysiology.

Atrial natriuretic peptide in spontaneous tachycardias.

E. Espiner, M. Nicholls, H. Ikram, 1987, British heart journal.

Atrial natriuretic peptides in man.

E. Espiner, M. Nicholls, H. Ikram, 1987, Canadian journal of physiology and pharmacology.

Effect of posture on clearance of atrial natriuretic peptide from plasma.

E. Espiner, M. Nicholls, I. Crozier, 1987, The Journal of clinical endocrinology and metabolism.

The AF-FICIENT magnetic resonance imaging and endoscopy safety substudy: A visually guided radiofrequency balloon ablation catheter for pulmonary vein isolation

A. Aidietis, M. Daly, I. Crozier, 2021, Heart rhythm O2.

Plasma corticotrophin releasing hormone, vasopressin, ACTH and Cortisol responses to acute myocardial infarction

A. Richards, H. Ikram, J. Livesey, 1994, Clinical endocrinology.

Inefficacy of daily single bolus dose atrial natriuretic factor in chronic congestive heart failure.

A. Richards, E. Espiner, M. Nicholls, 1989, American Journal of Cardiology.

Physiological role of atrial natriuretic peptide.

A. Richards, I. Crozier, A. Richards, 1989, International journal of cardiology.

Elevated atrial natriuretic factor in the plasma: cause or effect in "idiopathic orthostatic hypotension"?

A. Richards, I. Crozier, 1990, International journal of cardiology.

Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group.

M. Wilén, J. Cohn, E. Rapaport, 1988, JAMA.

Atrial natriuretic peptide in human hypertension.

A. Richards, E. Espiner, M. Nicholls, 1987, European heart journal.

Surgical radiofrequency ablation for atrial fibrillation: the Christchurch, New Zealand experience.

I. Crozier, Frith Coolbear, 2011, The New Zealand medical journal.

Cardiology Admissions Following the 2010 and 2011 Christchurch Earthquakes

D. Mcclean, I. Crozier, R. Troughton, 2011 .

Blockade of the renin-angiotensin system.

A. Richards, E. Espiner, M. Nicholls, 1994, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Antecedent hypertension and heart failure after myocardial infarction.

C. Frampton, A. Richards, E. Espiner, 2002, Journal of the American College of Cardiology.

Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure

William T. Abraham, Saibal Kar, Robert Doughty, 2010, Circulation.

Urocortin-2 infusion in acute decompensated heart failure: findings from the UNICORN study (urocortin-2 in the treatment of acute heart failure as an adjunct over conventional therapy).

C. Frampton, A. Richards, I. Crozier, 2013, JACC. Heart failure.

cardiomyopathy in New Zealand . The course of idiopathic dilated

H. Ikram, I. Crozier, E. Wells, 2005 .

The course of idiopathic dilated cardiomyopathy in New Zealand.

H. Ikram, I. Crozier, E. Wells, 1987, British heart journal.

Autonomic control of vasovagal syncope.

C. Frampton, H. Ikram, I. Crozier, 1998, American journal of physiology. Heart and circulatory physiology.

PPA2 gene is involved in neonatal fatal acute dilated cardiomyopathy

A. Rötig, S. Lyonnet, J. Amiel, 2018, Archives of Cardiovascular Diseases Supplements.

Continuous cardiac pacing for 53 years

I. Crozier, Bridget McIlraith, 2022, HeartRhythm Case Reports.

25 – Implantable Cardiac Rhythm and Hemodynamic Monitors

M. Daly, I. Crozier, I. Melton, 2017 .

High-Resolution Infrared Thermography of Esophageal Temperature During Radiofrequency Ablation of Atrial Fibrillation

M. Daly, I. Crozier, I. Melton, 2018, Circulation. Arrhythmia and electrophysiology.

Esophagopericardial Fistula Following Radiofrequency Ablation for Atrial Fibrillation

I. Crozier, Harsh P Singh, S. Kelly, 2021, JACC. Case reports.

An entirely subcutaneous implantable cardioverter-defibrillator.

Alexander H Maass, Johannes Sperzel, Riccardo Cappato, 2010, The New England journal of medicine.

Diagnostic Value of Comparison of Ventriculoatrial Interval During Junctional Tachycardia and Right Ventricular Apical Pacing

J. Camm, I. Crozier, D. Ward, 1989, Pacing and clinical electrophysiology : PACE.

Value of CT localization of the fossa ovalis prior to transseptal left heart catheterization for left atrial ablation.

Sharyn MacDonald, S. MacDonald, L. Graham, 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Penetrance and expressivity of the R858H CACNA1C variant in a five‐generation pedigree segregating an arrhythmogenic channelopathy

J. C. Jacobsen, J. Skinner, R. Snell, 2018, Molecular Genetics & Genomic Medicine.

Sudden Cardiac Death Due to Deficiency of the Mitochondrial Inorganic Pyrophosphatase PPA2

Colin A. Johnson, E. R. Baumgartner, T. Meitinger, 2016, American journal of human genetics.

Modern device technologies.

I. Crozier, Ian Crozier, Warren M. Smith, 2012, Heart, lung & circulation.

An Electrocardiogram That Never Grows Old

A. Sorgente, I. Crozier, William Bautista, 2019, JACC. Case reports.

Delayed Defibrillator Lead Perforation

I. Crozier, I. C. Melton, R. E. Park, 2008, Pacing and clinical electrophysiology : PACE.

The acute and chronic effects of losartan in heart failure

H. Ikram, I. Crozier, 1995, Journal of Hypertension - Supplement.

Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction

J G Turner, H Ikram, C. Frampton, 1999, Heart.

Ambulatory pulmonary arterial pressure in primary pulmonary hypertension: variability, relation to systemic arterial pressure, and plasma catecholamines.

A. Richards, M. Nicholls, H. Ikram, 1990, British heart journal.

Serial Doppler echocardiography and tissue Doppler imaging in the detection of elevated directly measured left atrial pressure in ambulant subjects with chronic heart failure.

R. Doughty, W. Abraham, A. Richards, 2011, JACC. Cardiovascular imaging.

Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.

R. Doughty, S. MacMahon, N. Sharpe, 2006, Journal of the American College of Cardiology.

Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator

Mark Kremers, Warren Smith, Michael R. Gold, 2013, Circulation.

Misdiagnosis of long QT syndrome as epilepsy at first presentation.

A. Shelling, J. Skinner, I. Crozier, 2009, Annals of emergency medicine.

How the Subcutaneous Implantable Cardioverter Defibrillator Works: Indications/Limitations and Special Groups to Consider

D. Hooks, I. Crozier, I. Melton, 2014 .

Fine tuning risk stratification for atrial fibrillation.

I. Crozier, R. Troughton, 2013, Journal of the American College of Cardiology.

Cardiac sarcoidosis: the Christchurch experience

S. MacDonald, I. Crozier, P. Adamson, 2014, Internal medicine journal.

Esophageal infrared thermography during atrial fibrillation ablation.

M. Daly, I. Crozier, Gary Lim, 2015, Heart Rhythm.

First-in-Human Chronic Implant Experience of the Substernal Extravascular Implantable Cardioverter-Defibrillator.

I. Crozier, A. Cheng, L. Sherfesee, 2020, JACC. Clinical electrophysiology.

The development of the extravascular defibrillator with substernal lead placement: A new Frontier for device‐based treatment of sudden cardiac arrest

B. Knight, G. Engel, B. Atwater, 2021, Journal of cardiovascular electrophysiology.

Therapy From a Novel Substernal Lead The Acute Extravascular De ﬁ brillation, Pacing, and Electrogram (ASD2) Study

P. Neužil, B. Knight, B. Merkely, 2018 .

Defibrillation threshold modeling to refine implant recommendations for an extravascular ICD system

J. Edmonson, I. Crozier, D. Swenson, 2020 .

Chronic follow-up from the pilot study of a novel substernal extravascular implantable cardioverter-defibrillator

I. Crozier, L. Sherfesee, P. Degroot, 2020 .

A prospective, randomized comparison in humans of defibrillation efficacy of a standard transvenous ICD system with a totally subcutaneous ICD system (The S-ICD® system)

R. Cappato, A. Grace, G. Bardy, 2005 .

Effects of AV Delay and VV Delay on Left Atrial Pressure and Waveform in Ambulant Heart Failure Patients: Insights into CRT Optimization

D. Gutfinger, K. Norén, I. Crozier, 2014, Pacing and clinical electrophysiology : PACE.

Radiofrequency ablation for common atrial flutter using an 8-mm tip catheter and up to 150 W.

I. Crozier, I. Melton, R. Hillock, 2005, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Images in cardiovascular medicine. Dynamic myocardial ischemia caused by circumflex artery stenosis detected by a new implantable left atrial pressure monitoring device.

Saibal Kar, Henry Krum, H. Krum, 2006, Circulation.

Electrophysiological Performance of a Bipolar Membrane‐Coated Titanium Nitride Electrode: A Randomized Comparison of Steroid and Nonsteroid Lead Designs

U. Wiegand, I. Crozier, R. Claessens, 1999, Pacing and clinical electrophysiology : PACE.

Management of atrial fibrillation in the emergency department

I. Crozier, S. Pearson, I. Melton, 2003, Internal medicine journal.

Yersinia enterocolitica associated myopericarditis: case report and review of the literature.

H. Nehoff, I. Crozier, H. Isenman, 2022, The New Zealand medical journal.

Human muscle sympathetic nerve responses to urocortin‐2 in health and stable heart failure

I. Crozier, C. Frampton, C. Charles, 2015, Clinical and experimental pharmacology & physiology.

The clinical, cardiac, renal, arterial and neurohormonal effects of omapatrilat, a vasopeptidase inhibitor, in patients with chronic heart failure.

A. H. Garlick, A. Richards, M. Nicholls, 2000, Journal of the American College of Cardiology.

Decrease in cardiac output and muscle sympathetic activity during vasovagal syncope.

C. Frampton, H. Ikram, I. Crozier, 2002, American journal of physiology. Heart and circulatory physiology.

Misdiagnosis of long QT syndrome as epilepsy at first presentation.

A. Shelling, J. Skinner, I. Crozier, 2009, Annals of emergency medicine.

Symptoms and signs associated with syncope in young people with primary cardiac arrhythmias.

A. Shelling, J. Skinner, I. Crozier, 2011, Heart, lung & circulation.

Fine tuning risk stratification for atrial fibrillation.

I. Crozier, R. Troughton, 2013, Journal of the American College of Cardiology.

Modern device technologies.

I. Crozier, Warren M. Smith, 2012, Heart, lung & circulation.